StockMarketWire.com - Liberum Capital today reaffirms its buy investment rating on PureTech Health Plc [LON:PRTC] and cut its price target to 420p (from 450p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk